Climara combined with Medroxyprogesterone

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Pain Other Serious Female 1/10/2006 Lawyer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 2/1/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/16/2001 49 Female 125 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Vomiting Other Serious 1/3/2000 52 Female 190 lb 3/31/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/2/2001 64 Female 4/11/2006 Lawyer United States
Primary
Secondary
Smear Cervix Abnormal Other Serious 5/9/2002 54 Female 153 lb 4/5/2006 Lawyer United States
Primary
Secondary
Concomitant
Vomiting Other Serious 7/9/2002 77 Female 130 lb 4/21/2006 United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 4/21/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 8/1/2004 65 Female 5/30/2006 United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 6/1/2006 Physician United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Hospitalization 5/9/2002 54 Female 153 lb 6/29/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 6/2/2001 64 Female 7/7/2006 Consumer United States
Primary
Secondary
Breast Cancer Required Intervention 1/14/2002 54 Female 145 lb 7/7/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 5/1/2000 Female 8/17/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/2/2001 Female 156 lb 12/30/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2004 65 Female 8/31/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2005 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2001 51 Female 140 lb 10/10/2006 United States
Primary
Secondary
Uterine Leiomyoma Other Serious 5/28/1997 62 Female 145 lb 1/26/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 8/27/2002 67 Female 2/7/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2001 Female 165 lb 2/22/2007 United States
Primary
Secondary
Concomitant
Respiratory Failure Other Serious 1/1/1998 53 Female 200 lb 2/23/2007 Consumer United States
Primary
Secondary
Concomitant
Scleroderma Other Serious 2/1/2006 Female 3/16/2007 Physician Canada
Primary
Concomitant
Breast Cancer Other Serious 5/1/2000 Female 12/22/2006 United States
Primary
Secondary
Scleroderma Other Serious 2/1/2006 Female 4/11/2007 Physician Canada
Primary
Concomitant
Breast Cancer Female Other Serious 5/1/2000 Female 2/7/2007 Consumer United States
Primary
Secondary
Breast Cancer In Situ Other Serious 12/27/2001 56 Female 138 lb 2/7/2007 Physician United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/2000 59 Female 156 lb 2/7/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 8/1/2004 65 Female 200 lb 2/7/2007 Lawyer United States
Primary
Secondary
Procedural Pain Other Serious 1/1/2003 57 Female 150 lb 2/7/2007 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Required Intervention 1/14/2002 54 Female 145 lb 7/5/2007 United States
Primary
Secondary
Concomitant
Mastectomy Other Serious 4/1/1911 65 Female 8/13/2007 Lawyer United States
Primary
Secondary
Tonsillectomy Other Serious 1/1/1992 67 Female 112 lb 11/15/2007 United States
Primary
Secondary
Concomitant
Unevaluable Event Other Serious 1/1/1992 67 Female 112 lb 9/17/2007 Lawyer United States
Primary
Secondary
Concomitant
Radiotherapy Other Serious 1/31/2001 1 Female 150 lb 9/17/2007 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 1/7/2002 Female 209 lb 12/12/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 10/15/1999 74 Female 12/18/2007 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 5/22/2000 Female 2/20/2008 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 10/1/2000 59 Female 157 lb 2/5/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 8/1/2004 65 Female 201 lb 9/12/2006 Lawyer United States
Primary
Secondary
Procedural Pain Other Serious 1/1/2003 57 Female 150 lb 10/4/2006 Lawyer United States
Primary
Secondary
Concomitant
Hepatitis Other Serious 1/1/1998 53 Female 201 lb 2/21/2007 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 1/7/2002 Female 209 lb 5/8/2008 Consumer United States
Primary
Secondary
White Blood Cell Count Decreased Other Serious 1/1/1994 Female 157 lb 6/19/2008 United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 1/7/2002 Female 209 lb 7/11/2008 Consumer United States
Primary
Secondary
Ventricular Extrasystoles Other Serious 2/1/2004 Female 200 lb 7/22/2008 United States
Primary
Secondary
Concomitant
Lung Neoplasm Malignant Other Serious 8/25/2000 65 Female 236 lb 8/18/2008 Lawyer United States
Primary
Secondary
Concomitant
Lung Neoplasm Malignant Other Serious 8/25/2000 65 Female 236 lb 10/2/2008 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/25/2002 57 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Female Other Serious 8/1/2004 64 Female 201 lb 11/10/2008 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2005 71 Female 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2001 51 Female 140 lb 10/9/2008 United States
Primary
Secondary
Breast Cancer Other Serious 10/31/2000 65 Female 140 lb 10/9/2008 United States
Primary
Secondary
Concomitant
Injury Other Serious Female 1/17/2009 Lawyer United States
Primary
Secondary
Concomitant
Cardiac Disorder Other Serious 3/25/1999 57 Female 12/19/2008 United States
Primary
Secondary
Ventricular Extrasystoles Other Serious 2/1/2004 Female 200 lb 1/30/2009 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 4/10/1997 53 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 12/21/2001 62 Female 12/19/2008 United States
Primary
Secondary
Osteoarthritis Other Serious 8/1/2004 64 Female 201 lb 2/11/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2001 59 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/21/2001 Female 126 lb 4/17/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 12/1/1999 Female 130 lb 5/25/2009 Lawyer United States
Primary
Secondary
Application Site Rash 8/18/2009 61 Female 10/26/2009 Pharmacist United States
Primary
Concomitant
Ventricular Extrasystoles Other Serious 2/1/2004 Female 200 lb 1/27/2010 United States
Primary
Secondary
Concomitant
Tonsillectomy Other Serious 1/1/1992 Female 112 lb 1/27/2010 United States
Primary
Secondary
Concomitant
Visual Impairment Other Serious 12/26/1998 Female 150 lb 2/25/2010 Other Health Professional United States
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 1/1/1994 Female 157 lb 3/9/2010 United States
Primary
Secondary
Concomitant
Visual Impairment Other Serious 12/26/1998 60 Female 150 lb 5/13/2010 Other Health Professional United States
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 1/1/1994 49 Female 157 lb 5/14/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 1/7/2002 65 Female 209 lb 5/24/2010 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/7/2002 65 Female 209 lb 5/24/2010 Consumer United States
Primary
Secondary
Endometrial Cancer Other Serious 1/1/2004 67 116 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/16/2001 49 Female 4/5/2010 United States
Primary
Secondary
Concomitant
Visual Impairment Other Serious 11/14/1998 60 Female 150 lb 8/10/2010 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 7/10/2000 62 Female 143 lb 8/24/2010 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 1/7/2002 65 Female 209 lb 8/26/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 3/1/2001 51 Female 140 lb 9/16/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious Female 9/17/2010 Lawyer United States
Primary
Secondary
Intestinal Prolapse Other Serious 1/1/1995 58 Female 9/17/2010 Lawyer United States
Primary
Secondary
Pain Other Serious 6/12/2003 64 Female 181 lb 10/19/2010 Other Health Professional United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 4/17/2002 54 Female 10/27/2010 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/7/2002 65 Female 209 lb 10/28/2010 Consumer United States
Primary
Secondary

Drug Data